[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600971":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":12,"collaborators":10,"id":14,"slug":10,"hasResults":15,"nctId":16,"briefTitle":17,"officialTitle":17,"acronym":18,"eligibilityCriteria":19,"healthyVolunteers":15,"sex":20,"minAge":21,"maxAge":10,"enrollmentInfo":22,"targetDuration":10,"studyType":25,"phases":10,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":10},{"fullName":5,"class":6},"Guangzhou University of Traditional Chinese Medicine","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"T2DM-CVD, T2DM-CeVD，T2DM-CVD&CeVD",null,"T2DM-CVD: Type 2 diabetes with ischemic cardiovascular disease (coronary artery disease\u002Fheart failure), excluding cerebrovascular involvement.\n\n2\\. T2DM-CeVD: Type 2 diabetes with ischemic cerebrovascular disease (ischemic stroke\u002FTIA), excluding cardiovascular involvement.\n\n3\\. T2DM-CVD\\&CeVD: Type 2 diabetes comorbid with both ischemic cardiovascular and cerebrovascular diseases.",{"type":13,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100600971",false,"NCT07104422","An Epidemiological and Long-Term Endpoint Registry Study on Disease-Syndrome Correlation Patterns in Comorbid Population With Diabetes and Ischemic Cardio-Cerebrovascular Disease","Diabetes","Inclusion Criteria:\n\n* Aged ≥ 18 years Diagnosed with comorbidities relevant to \"toxin-damaged collaterals\" theory (e.g., type 2 diabetes mellitus with cardiovascular\u002Fcerebrovascular disease).\n\nVoluntary participation with signed informed consent.\n\nExclusion Criteria:\n\n* Acute infectious diseases, malignant tumors, or autoimmune disorders. Mental illness or cognitive impairment affecting symptom assessment.","ALL","18 Years",{"count":23,"type":24},12000,"ESTIMATED","OBSERVATIONAL","Explore the characteristics of TCM syndrome elements and distribution patterns of syndrome types in comorbid populations; Screen for \"high-risk syndrome patterns\" and frequently co-occurring complex syndromes; Identify characteristic syndrome patterns at key stages: acute phase, recovery phase, and upon occurrence of endpoint events; Investigate the temporal evolution of TCM syndrome patterns and the disease-syndrome correlation patterns in comorbid patients.",[28,29],"Type 2 Diabetes Mellitus (T2DM)","Cardiovascular Complications",[31,32,33,34],"Diabetes comorbidities","Cardiovascular-cerebrovascular diseases","Real-world registry study","Disease-syndrome correlation","NOT_YET_RECRUITING","2025-07-29",{"date":38,"type":39},"2025-08-05","ACTUAL",{"date":41,"type":24},"2025-08-15",{"date":43,"type":24},"2028-07-30",{"name":5,"class":6}]